Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biao He

Showing results (331-340 of 346) with videos related to

Pageof 35
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 25, 2026
Diversity Patterns of Domestic Herbivore Viruses in China Reveal Transmission Dynamics with Disease Management ImplicationsYue Sun, Yong Li, Bagen Temur, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2014
Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancerMin-Li Mo, Jie Ma, Zhao Chen, et al.
Journal of Virology|March 21, 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primatesAshley C Beavis, Peng Xiao, Maria Cristina Gingerich, et al.
Cell|March 17, 2022
Virome characterization of game animals in China reveals a spectrum of emerging pathogensWan-Ting He, Xin Hou, Jin Zhao, et al.
Science Advances|July 4, 2025
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trialPaul Spearman, Hong Jin, Peng Xiao, et al.
Plos One|July 2, 2015
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell CarcinomasDongsheng Yue, Hui Li, Juanjuan Che, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2024
Isolation, characterization, and circulation sphere of a filovirus in fruit batsBiao He, Tingsong Hu, Xiaomin Yan, et al.
Journal of Virology|March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Science Advances|July 3, 2021
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccineDong An, Kun Li, Dawne K Rowe, et al.
Pageof 35

Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 25, 2026
Diversity Patterns of Domestic Herbivore Viruses in China Reveal Transmission Dynamics with Disease Management ImplicationsYue Sun, Yong Li, Bagen Temur, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2014
Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancerMin-Li Mo, Jie Ma, Zhao Chen, et al.
Journal of Virology|March 21, 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primatesAshley C Beavis, Peng Xiao, Maria Cristina Gingerich, et al.
Cell|March 17, 2022
Virome characterization of game animals in China reveals a spectrum of emerging pathogensWan-Ting He, Xin Hou, Jin Zhao, et al.
Science Advances|July 4, 2025
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trialPaul Spearman, Hong Jin, Peng Xiao, et al.
Plos One|July 2, 2015
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell CarcinomasDongsheng Yue, Hui Li, Juanjuan Che, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2024
Isolation, characterization, and circulation sphere of a filovirus in fruit batsBiao He, Tingsong Hu, Xiaomin Yan, et al.
Journal of Virology|March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variantsAshley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Science Advances|July 3, 2021
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccineDong An, Kun Li, Dawne K Rowe, et al.
Pageof 35